Aspira Women's Health (AWH) - Bathi mangsa ngarep

Vermillion (AWH) - logo korporat

The resilience of Aspira Women's Health (AWH) is based on the precision of Ova1Plus algorithms and the recognition of tests by insurers. The forward earnings metric confirms positive market expectations, where shows the current volume of the indicator. Margin growth is driven by the scaling of OvaWatch and physician awareness. The seamless nature of processes is guaranteed by streamlined air delivery of biomaterials to diagnostic centers.

Aspira Women's Health Inc (AWH): Prakiraan bathi perusahaan saka 04.07.2022 nganti 18.11.2026

AWH (Vermillion): rincian analitis lan laporan miturut indikator

Analisis dhasar perusahaan:AWH, Aspira Women's Health, Inc.
Barang utama Aspira Women's Health, Inc.

This indicator reflects the market consensus regarding the business's ability to generate net income in the future. The algorithm filters out short-term noise, establishing a fundamental valuation corridor through volatility analysis and the Sortino ratio. In the dynamics of prospective earnings, a breakout above the upper boundary signals either scaling or the risk of overpayment. For Aspira Women's Health (AWH), the growth of this metric confirms the commercial potential of Ova1 AI tests. High physician confidence in oncology diagnostics converts into the stability of projected profits.

Analisis pesaing

Bathi sing dikarepake Agilent Technologies, Inc.|Bathi sing dikarepake DGX|Bathi sing dikarepake Illumina Corp (ILMN)|Bathi sing dikarepake EXAS (Exact Sciences)|Revvity Inc - Bathi mangsa ngarep|Prakiraan bathi perusahaan Bio-Rad Laboratories (BIO)|NNNN - Bathi sing dikarepake|Prakiraan bathi perusahaan Sotera Health Corp SHC|QDEL: Proyeksi bathi mangsa ngarep|OPK - Prakiraan bathi perusahaan|Bathi sing dikarepake CareDx|maravai.com (MRVI) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep FLGT|Bathi resik mangsa ngarep LAB|cytekbio.com - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSUR|exagen.com - Proyeksi bathi mangsa ngarep|MDXH (MDxHealth SA) - Prakiraan bathi resik|LUCD: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Prenetics Global (PRE)|IMDX (Insight Molecular Diagnostics) - Proyeksi bathi mangsa ngarep|Trinity Biotech (TRIB) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep PRPH|AIMD (Ainos, Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CODX (codiagnostics.com)|Bathi resik mangsa ngarep HSCS (HeartSciences)|Biomerica Inc - Proyeksi bathi mangsa ngarep|CDIO (cardiodiagnosticsinc.com) - Prakiraan bathi resik|ONCO (Onconetix) - Bathi mangsa ngarep|Bathi resik sing dikarepake viraxbiolabs.com (VRAX)|BJDX (Bluejay Diagnostics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Accelerate Diagnostics, Inc AXDX|Bathi sing dikarepake CENTOGENE, N.V. (CNTG)|Bathi mangsa ngarep Enzo ENZ|Fresh2 Group Limited (FRES) - Bathi forward|Penghasilan resik sing dikarepake GENE|ME: Bathi mangsa ngarep|Psychemedics Corporation (PMD) - Bathi mangsa ngarep